Contents | 45 of 76

Complications of Cancer Therapy

Update Item Information
Title Walsh and Hoyt's Clinical Neuro-Ophthalmology
Subject Neurology; Ophthalmology; Eye Diseases
Description Walsh and Hoyt's Clinical Neuro-Ophthalmology
Date 2005
Language eng
Format application/pdf
Type Text
Collection Neuro-Ophthalmology Virtual Education Library: Walsh and Hoyt Textbook Collection: https://novel.utah.edu/collection/walsh-and-hoyt/
Holding Institution Spencer S. Eccles Health Sciences Library, University of Utah
Rights Management North American Neuro-Ophthalmology Association (NANOS), Copyright 2011. For further information regarding the rights to this collection, please visit http://library.med.utah.edu/NOVEL/about/copyright
ARK ark:/87278/s6rj4hsw
Setname ehsl_novel_wht
ID 190107
Reference URL https://collections.lib.utah.edu/ark:/87278/s6rj4hsw

Page Metadata

Identifier CH37_1759-1820
Title Complications of Cancer Therapy
Alternative Title Section 7: Chapter 37
Creator Mark L. Moster, MD, Thomas Jefferson University; Rod Foroozan, M.D., Baylor College of Medicine
Affiliation Thomas Jefferson School of Medicine and Albert Einstein Medical Center and Wills Eye Institute; Baylor College of Medicine
Subject Neoplasms; Neoplasms, Therapy; Chemotherapy, Adverse Effects; Radiotherapy, Adverse Effects; Bone Marrow Transplantation, Adverse Effects
Description "Patients with cancer frequently have neurologic, ophthalmologic, or neuro-ophthalmologic complications."
Abstract "Patients with cancer frequently have neurologic, ophthalmologic, or neuro-ophthalmologic complications. Often, such patients have received multiple different treatments, including chemotherapy, radiation therapy (RT), and bone marrow transplantation (BMT). The differential diagnosis of the presenting problem thus may be quite complex. One possibility is a direct effect of the cancer itself, either by metastasis or local spread. A remote paraneoplastic syndrome is another. Direct toxicity may occur from chemotherapy or RT. Toxicity may be a secondary effect, such as a drug-induced hemorrhage from thrombocytopenia or an infection from immunosuppression. Metabolic disturbances from multiple causes can produce systemic, neurologic, and ocular deficits, and multiple treatment modalities may be additive in causing neurologic or ophthalmologic toxicity. Finally, the possibility always exists that the new symptoms are totally unrelated to the cancer or its therapy."
Language eng
Format application/pdf
Type Text
Publication Type Book chapter
Rights Management North American Neuro-Ophthalmology Association (NANOS), Copyright 2011. For further information regarding the rights to this collection, please visit http://library.med.utah.edu/NOVEL/about/copyright
Extent 2.3 MB
Setname ehsl_novel_wht
ID 190075
Reference URL https://collections.lib.utah.edu/ark:/87278/s6rj4hsw/190075